rs6 phosphoprotein Search Results


kda ribosomal protein s6 kinase p70s6k inhibitor  (MedChemExpress)
92
MedChemExpress kda ribosomal protein s6 kinase p70s6k inhibitor
<t>P70S6K</t> is involved in serotonin mediated hepatocyte proliferation. (A,B) Immunoblotting of phospho-p70S6K/p70S6K was performed in WT and ST2−/− livers at 0 h and 12 h after PHx. The ratios of p-p70S6K/β-actin were quantified (n = 3/group). (C,D) WT and ST2−/− livers treated with saline or DOI were collected at 12 h after PHx. Immunoblotting of phospho-p70S6K/p70S6K was performed and the ratios of p-p70S6K/β-actin quantified (n = 3/group). (E,F) Primary murine hepatocytes were isolated and treated with DOI after serum starvation. Phospho-p70S6K was measured by immunoblotting, and the ratios of p-p70S6K/β-actin from three independent experiments were quantified. (G,H) Primary murine hepatocytes were treated with DOI or an p70S6K inhibitor (p70S6Ki). The levels of PCNA were measured by immunoblotting. The ratios of PCNA/β-actin from three independent experiments were quantified. Two-way ANOVA was performed in (B), (D), (F), and (H)
Kda Ribosomal Protein S6 Kinase P70s6k Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rs6+phosphoprotein/Phospho-RPS6+(Ser235%2FSer236)+Antibody/pmc10758291-98-30-38
Average 92 stars, based on 1 article reviews
kda ribosomal protein s6 kinase p70s6k inhibitor - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
α sma antibodies  (Boster Bio)
90
Boster Bio α sma antibodies
<t>P70S6K</t> is involved in serotonin mediated hepatocyte proliferation. (A,B) Immunoblotting of phospho-p70S6K/p70S6K was performed in WT and ST2−/− livers at 0 h and 12 h after PHx. The ratios of p-p70S6K/β-actin were quantified (n = 3/group). (C,D) WT and ST2−/− livers treated with saline or DOI were collected at 12 h after PHx. Immunoblotting of phospho-p70S6K/p70S6K was performed and the ratios of p-p70S6K/β-actin quantified (n = 3/group). (E,F) Primary murine hepatocytes were isolated and treated with DOI after serum starvation. Phospho-p70S6K was measured by immunoblotting, and the ratios of p-p70S6K/β-actin from three independent experiments were quantified. (G,H) Primary murine hepatocytes were treated with DOI or an p70S6K inhibitor (p70S6Ki). The levels of PCNA were measured by immunoblotting. The ratios of PCNA/β-actin from three independent experiments were quantified. Two-way ANOVA was performed in (B), (D), (F), and (H)
α Sma Antibodies, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rs6+phosphoprotein/Anti-Phospho-Ribosomal+Protein+S6+(Ser244)+Antibody/pm24603476-65-5-10
Average 90 stars, based on 1 article reviews
α sma antibodies - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


P70S6K is involved in serotonin mediated hepatocyte proliferation. (A,B) Immunoblotting of phospho-p70S6K/p70S6K was performed in WT and ST2−/− livers at 0 h and 12 h after PHx. The ratios of p-p70S6K/β-actin were quantified (n = 3/group). (C,D) WT and ST2−/− livers treated with saline or DOI were collected at 12 h after PHx. Immunoblotting of phospho-p70S6K/p70S6K was performed and the ratios of p-p70S6K/β-actin quantified (n = 3/group). (E,F) Primary murine hepatocytes were isolated and treated with DOI after serum starvation. Phospho-p70S6K was measured by immunoblotting, and the ratios of p-p70S6K/β-actin from three independent experiments were quantified. (G,H) Primary murine hepatocytes were treated with DOI or an p70S6K inhibitor (p70S6Ki). The levels of PCNA were measured by immunoblotting. The ratios of PCNA/β-actin from three independent experiments were quantified. Two-way ANOVA was performed in (B), (D), (F), and (H)

Journal: Hepatology (Baltimore, Md.)

Article Title: Interleukin-33 facilitates liver regeneration through serotonin-involved gut-liver axis

doi: 10.1002/hep.32744

Figure Lengend Snippet: P70S6K is involved in serotonin mediated hepatocyte proliferation. (A,B) Immunoblotting of phospho-p70S6K/p70S6K was performed in WT and ST2−/− livers at 0 h and 12 h after PHx. The ratios of p-p70S6K/β-actin were quantified (n = 3/group). (C,D) WT and ST2−/− livers treated with saline or DOI were collected at 12 h after PHx. Immunoblotting of phospho-p70S6K/p70S6K was performed and the ratios of p-p70S6K/β-actin quantified (n = 3/group). (E,F) Primary murine hepatocytes were isolated and treated with DOI after serum starvation. Phospho-p70S6K was measured by immunoblotting, and the ratios of p-p70S6K/β-actin from three independent experiments were quantified. (G,H) Primary murine hepatocytes were treated with DOI or an p70S6K inhibitor (p70S6Ki). The levels of PCNA were measured by immunoblotting. The ratios of PCNA/β-actin from three independent experiments were quantified. Two-way ANOVA was performed in (B), (D), (F), and (H)

Article Snippet: After 4 h, the culture medium was deprived of fetal bovine serum (FBS) for at least 48 h. Subsequently, hepatocytes were treated with 5 μM DOI or 10 μM 70 kDa ribosomal protein S6 kinase (p70S6K) inhibitor, LY-2584702 (MedChemExpress), in 5% FBS.

Techniques: Western Blot, Saline, Isolation

Proposed mechanism of IL-33/ST2 regulated liver regeneration. After PHx, IL-33/ST2 signaling in enterochromaffin cells enhances serotonin release. Through the portal blood, serotonin travels into the liver where it binds to HTR2A and activates p70S6K, thereby contributing to hepatocyte proliferation

Journal: Hepatology (Baltimore, Md.)

Article Title: Interleukin-33 facilitates liver regeneration through serotonin-involved gut-liver axis

doi: 10.1002/hep.32744

Figure Lengend Snippet: Proposed mechanism of IL-33/ST2 regulated liver regeneration. After PHx, IL-33/ST2 signaling in enterochromaffin cells enhances serotonin release. Through the portal blood, serotonin travels into the liver where it binds to HTR2A and activates p70S6K, thereby contributing to hepatocyte proliferation

Article Snippet: After 4 h, the culture medium was deprived of fetal bovine serum (FBS) for at least 48 h. Subsequently, hepatocytes were treated with 5 μM DOI or 10 μM 70 kDa ribosomal protein S6 kinase (p70S6K) inhibitor, LY-2584702 (MedChemExpress), in 5% FBS.

Techniques: